Sympathies, I am on the same path.
Stage 4 Colon cancer 2022 then chemo & radiation followed by surgery colon & section 6 of liver then 12 doses Folfox now metastic colon cancer in lung currently considering experimental procedures with Moffit Cancer Specialists here in USA.
Chin up !
Sympathies, I am on the same path.
Stage 4 Colon cancer 2022 then chemo & radiation followed by surgery colon & section 6 of liver then 12 doses Folfox now metastic colon cancer in lung currently considering experimental procedures with Moffit Cancer Specialists here in USA.
Chin up !
Read more ➡️: www.onclive.com/view/nexera-...
Read more ➡️: www.onclive.com/view/nexera-...
Our booklets include information about:
- Gemcitabine, cisplatin and durvalumab
- FOLFOX
- Ivosidenib
- Pemigatinib
- Futibatinib
Download the booklets from our website:
https://ammf.org.uk/patient-resources/
For a hard copy email: info@ammf.org.uk.
Our booklets include information about:
- Gemcitabine, cisplatin and durvalumab
- FOLFOX
- Ivosidenib
- Pemigatinib
- Futibatinib
Download the booklets from our website:
https://ammf.org.uk/patient-resources/
For a hard copy email: info@ammf.org.uk.
worthington looks "fine" except he seems to have his name on a really wide array of article topics moreso than being a published "expert" on any singular subject
worthington looks "fine" except he seems to have his name on a really wide array of article topics moreso than being a published "expert" on any singular subject
Read more ➡️: www.onclive.com/view/qtx3034...
Read more ➡️: www.onclive.com/view/qtx3034...
➡️ Wir haben untersucht, ob Encorafenib in Kombination mit den Wirkstoffen Cetuximab und einer Chemotherapie (FOLFOX) bei der Erstlinienbehandlung Erwachsener mit metastasiertem […]
[Original post on wisskomm.social]
➡️ Wir haben untersucht, ob Encorafenib in Kombination mit den Wirkstoffen Cetuximab und einer Chemotherapie (FOLFOX) bei der Erstlinienbehandlung Erwachsener mit metastasiertem […]
[Original post on wisskomm.social]
WATCH: Moh’d Khushman, MD, of @sitemancenter.bsky.social, discusses the rationale and design of the phase 3 INCA033890-303 trial.
www.onclive.com/view/dr-khus...
WATCH: Moh’d Khushman, MD, of @sitemancenter.bsky.social, discusses the rationale and design of the phase 3 INCA033890-303 trial.
www.onclive.com/view/dr-khus...
https://mdsc.pe/4AjgTuP
https://mdsc.pe/4AjgTuP
journals.physiology.org/doi/abs/10.1...
journals.physiology.org/doi/abs/10.1...
music.youtube.com/watch?v=-aVx...
music.youtube.com/watch?v=-aVx...
BREAKWATER Update in #ColorectalCancer
Source PR NewsWire
www.prnewswire.com/news-release...
Pierre Fabre announced European Commission approval of encorafenib plus cetuximab and FOLFOX as first-line treatment for adults with BRAFV600E-mutant metastatic colorectal cancer.
BREAKWATER Update in #ColorectalCancer
Source PR NewsWire
www.prnewswire.com/news-release...
Pierre Fabre announced European Commission approval of encorafenib plus cetuximab and FOLFOX as first-line treatment for adults with BRAFV600E-mutant metastatic colorectal cancer.
i guess after that we try a 3rd regimen, which may not work, like the 1st one we did. i'm not looking forward to losing more precious time on ineffective treatments
i guess after that we try a 3rd regimen, which may not work, like the 1st one we did. i'm not looking forward to losing more precious time on ineffective treatments